Your browser doesn't support javascript.
loading
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Dupont, Benoît; Mariotte, Delphine; Dugué, Audrey E; Clarisse, Bénédicte; Grellard, Jean-Michel; Babin, Emmanuel; Chauffert, Bruno; Dakpé, Stéphanie; Moldovan, Cristian; Bouhier-Leporrier, Karine; Reimund, Jean-Marie; Di Fiore, Frederic; Zanetta, Sylvie; Mailliez, Audrey; Do, Pascal; Peytier, Annie; Galais, Marie-Pierre; Florescu, Carmen; Schott, Roland; Le Mauff, Brigitte; Gervais, Radj.
  • Dupont B; Department of Hepato-Gastroenterology and Nutrition, CHU de Caen, Caen, France.
  • Mariotte D; Laboratory of Immunology and Immunopathology, CHU de Caen, Caen, France.
  • Dugué AE; Clinical Research Department, Centre François Baclesse, Caen, France.
  • Clarisse B; Clinical Research Department, Centre François Baclesse, Caen, France.
  • Grellard JM; Clinical Research Department, Centre François Baclesse, Caen, France.
  • Babin E; Department of Otolaryngology-Head and Neck Surgery, CHU de Caen, Caen, France.
  • Chauffert B; Medical Oncology Department, CHU d'Amiens, Amiens, France.
  • Dakpé S; Department of Maxillofacial Surgery and Stomatology, CHU d'Amiens, Amiens, France.
  • Moldovan C; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.
  • Bouhier-Leporrier K; Department of Hepato-Gastroenterology and Nutrition, CHU de Caen, Caen, France.
  • Reimund JM; Department of Hepato-Gastroenterology and Nutrition, CHU de Caen, Caen, France.
  • Di Fiore F; Department of Hepato-Gastroenterology and Nutritional Support, CHU de Strasbourg, Strasbourg, France.
  • Zanetta S; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.
  • Mailliez A; Digestive Oncology Unit, Gastroenterology Department, CHU de Rouen, Rouen, France.
  • Do P; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France.
  • Peytier A; Head and Neck Department, Centre Oscar Lambret, Lille, France.
  • Galais MP; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Florescu C; Gastroenterology Department, Centre Hospitalier de Bayeux, Bayeux, France.
  • Schott R; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Le Mauff B; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Gervais R; Medical Oncology Department, Centre Paul Strauss, Strasbourg, France.
Br J Clin Pharmacol ; 83(3): 623-631, 2017 03.
Article en En | MEDLINE | ID: mdl-27662818
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina E / Hipersensibilidad a las Drogas / Cetuximab Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina E / Hipersensibilidad a las Drogas / Cetuximab Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article